Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
Read Article
News
2024
2023
Archive
Search news articles
January 7, 2019
Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities
January 6, 2019
Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
January 4, 2019
Arvinas Receives Authorization To Proceed For Its IND Application For PROTAC™ Therapy
January 4, 2019
Pear Therapeutics Completes $64M Series C Financing
January 3, 2019
Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cell-Mediated Autoimmune Diseases
January 2, 2019
Flexion Therapeutics Enrolls First Patient in Phase 3 Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in OA of the Hip and Reports Results from SHIP Study
December 18, 2018
Ceterix is pleased to announce that we have entered into a definitive agreement to be acquired by Smith & Nephew
December 18, 2018
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
December 12, 2018
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
December 12, 2018
Cell Therapy Industry Pioneer, Gwendolyn Binder, Ph.D., to Join Cabaletta Bio Leadership Team
« Previous Page
1
…
70
71
72
73
74
…
118
Next Page »